KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) Other Non Operating Income (2018 - 2025)

Castle Biosciences (CSTL) has disclosed Other Non Operating Income for 4 consecutive years, with $96000.0 as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income changed N/A to $96000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $144000.0 through Dec 2025, up 110.29% year-over-year, with the annual reading at $144000.0 for FY2025, N/A changed from the prior year.
  • Other Non Operating Income hit $96000.0 in Q4 2025 for Castle Biosciences, up from $48000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $96000.0 in Q4 2025 to a low of $48000.0 in Q3 2025.